acetaminophen has been researched along with mitotempo in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, K; Farhood, A; Jaeschke, H | 1 |
| Chao, X; Ding, WX; Du, K; Jaeschke, AH; Jaeschke, H; Ramachandran, A; Weemhoff, JL; Woolbright, BL | 1 |
2 other study(ies) available for acetaminophen and mitotempo
| Article | Year |
|---|---|
Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity.
Topics: Acetaminophen; Activation, Metabolic; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Cyclic N-Oxides; Male; MAP Kinase Kinase 4; Mice, Inbred C57BL; Mitochondria, Liver; Organophosphorus Compounds; Oxidative Stress; Piperidines; Protective Agents | 2017 |
Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity.
Topics: Acetaminophen; Acetylcysteine; Animals; Antioxidants; Apoptosis; Caspase 3; Chemical and Drug Induced Liver Injury; Hepatocytes; Male; Mice, Inbred C57BL; Necrosis; Organophosphorus Compounds; Piperidines; Receptor-Interacting Protein Serine-Threonine Kinases | 2019 |